ClinicalTrials.gg
Status unknownNCT02317718Updated Dec 16, 2014

Serum Vitamin D Level and Its Association With Ovarian Reserve and IVF Outcome

An observational study in VITAMIN D Disorders, sponsored by Fakih IVF Fertility Center. Status unknown at 1 site in United Arab Emirates. Open to female participants aged 20 Years to 42 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-12-16.

Sponsored by Fakih IVF Fertility Center · Observational

How we know

The sponsor has not verified this record recently (last verified Dec 2014), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Ages
20 Years to 42 Years
Sex
Female
01

Study summary

Vitamin D has a major play in bone and calcium metabolism. Vitamin D deficiency (below 20 ng/ml) has also been linked to adverse health outcomes such as malignancy, cardiovascular disease, immune functioning, and glucose metabolism. Recent data from retrospective and prospective trials have demonstrated contradictive results concerning the role of vitamin D in female reproduction and IVF outcome. Some studies have found that women deficient in vitamin D had lower ovarian reserve and significantly lower clinical pregnancy rates when compared to patients who were sufficient levels in vitamin D. Some studies also demonstrated that serum 25-OH-D3 levels correlates with antimullerian hormone (AMH) levels in women of advanced reproductive age. It may also have a role to play in endocrine dysfunction and abnormal folliculogenesis in polycystic ovaries .

The aim of this prospective cohort study including infertile women undergoing IVF treatment is to investigate the association between serum 25-OH- D3 levels and parametres of ovarian reserve (AMH, antral follicle count, number of oocytes collected) and clinical pregnancy and miscarriage rates .

Read the detailed description

Vitamin D has a major play in bone and calcium metabolism. Vitamin D deficiency (below 20 ng/ml) has also been linked to adverse health outcomes such as malignancy, cardiovascular disease, immune functioning, and glucose metabolism. Recent data from retrospective and prospective trials have demonstrated contradictive results concerning the role of vitamin D in female reproduction and IVF outcome. Some studies have found that women deficient in vitamin D had lower ovarian reserve and significantly lower clinical pregnancy rates when compared to patients who were sufficient levels in vitamin D. Some studies also demonstrated that serum 25-OH-D3 levels correlates with antimullerian hormone (AMH) levels in women of advanced reproductive age. It may also have a role to play in endocrine dysfunction and abnormal folliculogenesis in polycystic ovaries .

The aim of this prospective cohort study including infertile women undergoing IVF treatment is to investigate the association between serum 25-OH- D3 levels and parametres of ovarian reserve (AMH, antral follicle count, number of oocytes collected) and clinical pregnancy and miscarriage rates .

02

Conditions studied

  • VITAMIN D Disorders

Keywords

  • serum vitamin D levels
  • IVF
  • ovarian reserve
  • 25 OHD3
  • pregnancy outcome
03

In context

Lead sponsor

Fakih IVF Fertility Center is the lead sponsor of 6 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 42 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Women undergoing IVF between 20-42 years of age

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subfertile women,
  • Indication for IVF,
  • 20-42 yrs of age.

Exclusion criteria

Exclusion Criteria:

  • Women on therapeutic supplementation for Vitamin D Deficiency,
  • Recurrent high order implantation failure
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes

Groups and cohorts

  • Normal vitamin D levels group

    MORE THAN 20 NG/ML VITAMIN D LEVELS

    Other: monitor reproductive outcome

  • Deficient Vitamin D GROUP

    LESS THAN 20 NG/ML LEVELS

    Other: monitor reproductive outcome

Interventions

  • Othermonitor reproductive outcome
06

What researchers measure

Primary outcomes

  1. Clinical pregnancy rate

    Time frame: 14 days post oocyte retrieval

Secondary outcomes

  1. AMH (antimullerian hormone) Levels

    Time frame: day 2-3 of the index cycle

  2. AFC (antral follicle count)

    Time frame: DAY 2-3 OF INDEX CYCLE

  3. Number of oocytes retreived

    Time frame: Two weeks from the last menstrual period

07

Study locations

1 of 1 sites recruiting
  • Fakihivf Fertiity Center
    Abudhabi, Abu Dhabi 31453, United Arab Emirates
    Recruiting
    • MONIKA CHAWLA, MD · Contact97124444107
08

References and documents

Publications

  • Paffoni A, Ferrari S, Vigano P, Pagliardini L, Papaleo E, Candiani M, Tirelli A, Fedele L, Somigliana E. Vitamin D deficiency and infertility: insights from in vitro fertilization cycles. J Clin Endocrinol Metab. 2014 Nov;99(11):E2372-6. doi: 10.1210/jc.2014-1802. Epub 2014 Aug 14. PubMed 25121462 ↗
  • Polyzos NP, Anckaert E, Guzman L, Schiettecatte J, Van Landuyt L, Camus M, Smitz J, Tournaye H. Vitamin D deficiency and pregnancy rates in women undergoing single embryo, blastocyst stage, transfer (SET) for IVF/ICSI. Hum Reprod. 2014 Sep;29(9):2032-40. doi: 10.1093/humrep/deu156. Epub 2014 Jun 20. PubMed 24951484 ↗
  • Fabris A, Pacheco A, Cruz M, Puente JM, Fatemi H, Garcia-Velasco JA. Impact of circulating levels of total and bioavailable serum vitamin D on pregnancy rate in egg donation recipients. Fertil Steril. 2014 Dec;102(6):1608-12. doi: 10.1016/j.fertnstert.2014.08.030. Epub 2014 Sep 23. PubMed 25256926 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2014, a primary completion of Jun 2015 and a completion of Jul 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2014
First posted
Dec 16, 2014
Start
Dec 2014
Primary completionEst.
Jun 2015
CompletionEst.
Jul 2015
Last update
Dec 16, 2014
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 16, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02317718
Lead sponsor
Fakih IVF Fertility Center
Responsible party
monika chawla (Specialist Reproductive Endocrinology and Infertility, Fakih IVF Fertility Center) — Principal investigator
First posted
Dec 16, 2014
Start date
Dec 2014
Primary completion
Jun 2015 (estimated)
Completion
Jul 2015 (estimated)
Last update
Dec 16, 2014

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion